These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 15185310)
1. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Cha MY; Kim CM; Park YM; Ryu WS Hepatology; 2004 Jun; 39(6):1683-93. PubMed ID: 15185310 [TBL] [Abstract][Full Text] [Related]
2. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842 [TBL] [Abstract][Full Text] [Related]
3. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Hsieh A; Kim HS; Lim SO; Yu DY; Jung G Cancer Lett; 2011 Jan; 300(2):162-72. PubMed ID: 20971552 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650 [TBL] [Abstract][Full Text] [Related]
8. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis. Bhatia N; Spiegelman VS Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534 [TBL] [Abstract][Full Text] [Related]
9. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100 [TBL] [Abstract][Full Text] [Related]
10. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286 [TBL] [Abstract][Full Text] [Related]
11. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000 [TBL] [Abstract][Full Text] [Related]
12. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Spychala J; Kitajewski J Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841 [TBL] [Abstract][Full Text] [Related]
13. A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis. Nakamura T; Sano M; Songyang Z; Schneider MD Proc Natl Acad Sci U S A; 2003 May; 100(10):5834-9. PubMed ID: 12719544 [TBL] [Abstract][Full Text] [Related]
14. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329 [TBL] [Abstract][Full Text] [Related]
15. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505 [TBL] [Abstract][Full Text] [Related]
16. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688 [TBL] [Abstract][Full Text] [Related]
17. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729 [TBL] [Abstract][Full Text] [Related]
18. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900 [TBL] [Abstract][Full Text] [Related]